These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33455918)

  • 1. Arg206Cys substitution in
    Coke LN; Wen H; Comeau M; Ghanem MH; Shih A; Metz CN; Li W; Langefeld CD; Gregersen PK; Simpfendorfer KR
    Ann Rheum Dis; 2021 Jun; 80(6):782-787. PubMed ID: 33455918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the DNASE1L3 rs35677470 polymorphism with systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis: Structural biological insights.
    Zervou MI; Andreou A; Matalliotakis M; Spandidos DA; Goulielmos GN; Eliopoulos EE
    Mol Med Rep; 2020 Dec; 22(6):4492-4498. PubMed ID: 33173951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.
    Zochling J; Newell F; Charlesworth JC; Leo P; Stankovich J; Cortes A; Zhou Y; Stevens W; Sahhar J; Roddy J; Nash P; Tymms K; Rischmueller M; Lester S; Proudman S; Brown MA
    Arthritis Res Ther; 2014 Oct; 16(5):438. PubMed ID: 25332064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6.
    Oparina NY; Delgado-Vega AM; Martinez-Bueno M; Magro-Checa C; Fernández C; Castro RO; Pons-Estel BA; D'Alfonso S; Sebastiani GD; Witte T; Lauwerys BR; Endreffy E; Kovács L; Escudero A; López-Pedrera C; Vasconcelos C; da Silva BM; Frostegård J; Truedsson L; Martin J; Raya E; Ortego-Centeno N; de Los Angeles Aguirre M; de Ramón Garrido E; Palma MJ; Alarcon-Riquelme ME; Kozyrev SV
    Ann Rheum Dis; 2015 Mar; 74(3):e14. PubMed ID: 24534757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Impaired DNASE1L3 Activity to Anti-DNA Autoantibody Production in Systemic Lupus Erythematosus.
    Mathapathi S; Chu CQ
    Rheumatol Immunol Res; 2022 Mar; 3(1):17-22. PubMed ID: 36467024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual-acting DNASE1/DNASE1L3 biologic prevents autoimmunity and death in genetic and induced lupus models.
    Stabach PR; Sims D; Gomez-Bañuelos E; Zehentmeier S; Dammen-Brower K; Bernhisel A; Kujawski S; Lopez SG; Petri M; Goldman DW; Lester ER; Le Q; Ishaq T; Kim H; Srivastava S; Kumar D; Pereira JP; Yarema KJ; Koumpouras F; Andrade F; Braddock DT
    JCI Insight; 2024 Jun; 9(14):. PubMed ID: 38888971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dnase1l3 deficiency in lupus-prone MRL and NZB/W F1 mice.
    Wilber A; O'Connor TP; Lu ML; Karimi A; Schneider MC
    Clin Exp Immunol; 2003 Oct; 134(1):46-52. PubMed ID: 12974753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum level of DNase1l3 in patients with dermatomyositis/polymyositis, systemic lupus erythematosus and rheumatoid arthritis, and its association with disease activity.
    Zhao Q; Yang C; Wang J; Li Y; Yang P
    Clin Exp Med; 2017 Nov; 17(4):459-465. PubMed ID: 28039554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus.
    Carbonella A; Mancano G; Gremese E; Alkuraya FS; Patel N; Gurrieri F; Ferraccioli G
    Lupus; 2017 Jun; 26(7):768-772. PubMed ID: 27821515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus.
    Al-Mayouf SM; Sunker A; Abdwani R; Abrawi SA; Almurshedi F; Alhashmi N; Al Sonbul A; Sewairi W; Qari A; Abdallah E; Al-Owain M; Al Motywee S; Al-Rayes H; Hashem M; Khalak H; Al-Jebali L; Alkuraya FS
    Nat Genet; 2011 Oct; 43(12):1186-8. PubMed ID: 22019780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A monogenic lupus family caused by homozygous deletions of DNASE1L3 gene and literature review].
    Wang W; Li XL; Li WD; Ou JB; Gao SH; Zhang CH; Liu YL; Sun ZC; Ma MS; Song HM
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1276-1281. PubMed ID: 36444430
    [No Abstract]   [Full Text] [Related]  

  • 12. Deficiency of macrophage-derived Dnase1L3 causes lupus-like phenotypes in mice.
    Engavale M; Hernandez CJ; Infante A; LeRoith T; Radovan E; Evans L; Villarreal J; Reilly CM; Sutton RB; Keyel PA
    J Leukoc Biol; 2023 Nov; 114(6):547-556. PubMed ID: 37804110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus.
    Korn MA; Steffensen M; Brandl C; Royzman D; Daniel C; Winkler TH; Nitschke L
    Front Immunol; 2023; 14():1095830. PubMed ID: 36969253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CD40 polymorphisms and haplotype with risk of systemic lupus erythematosus.
    Wu CJ; Guo J; Luo HC; Wei CD; Wang CF; Lan Y; Wei YS
    Rheumatol Int; 2016 Jan; 36(1):45-52. PubMed ID: 26289938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A haplotype confers susceptibility to systemic lupus erythematosus but not to rheumatoid arthritis in Mexican patients.
    Montúfar-Robles I; Barbosa-Cobos RE; Alemán-Ávila I; Ramírez-Bello J
    Int J Rheum Dis; 2019 Mar; 22(3):473-479. PubMed ID: 30398030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothers of children with neonatal lupus.
    Cherian TS; Kariuki SN; Franek BS; Buyon JP; Clancy RM; Niewold TB
    Arthritis Rheum; 2012 Oct; 64(10):3383-7. PubMed ID: 22674082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.
    Bruschi M; Bonanni A; Petretto A; Vaglio A; Pratesi F; Santucci L; Migliorini P; Bertelli R; Galetti M; Belletti S; Cavagna L; Moroni G; Franceschini F; Fredi M; Pazzola G; Allegri L; Sinico RA; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Ramoino P; Bianchini P; Puppo F; Pupo F; Negrini S; Mattana F; Emmi G; Garibotto G; Santoro D; Scolari F; Ravelli A; Tincani A; Cravedi P; Volpi S; Candiano G; Ghiggeri GM
    J Rheumatol; 2020 Mar; 47(3):377-386. PubMed ID: 31092713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of the folate metabolizing enzymes: Association with SLE susceptibility and in silico analysis.
    Salimi S; Keshavarzi F; Mohammadpour-Gharehbagh A; Moodi M; Mousavi M; Karimian M; Sandoughi M
    Gene; 2017 Dec; 637():161-172. PubMed ID: 28943344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the programmed cell death 1 (PDCD1) polymorphisms in susceptibility to systemic lupus erythematosus.
    Fathi F; Sadeghi E; Lotfi N; Hafezi H; Ahmadi M; Mozafarpoor S; Motedayyen H
    Int J Immunogenet; 2020 Feb; 47(1):57-64. PubMed ID: 31565862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.